Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 9;22(1):325.
doi: 10.1186/s12888-022-03967-3.

Mortality in individuals with childhood ADHD or subthreshold symptoms - a prospective perinatal risk cohort study over 40 years

Nella Schiavone  1 , Maarit Virta  2 , Sami Leppämäki  3 , Jyrki Launes  2 , Ritva Vanninen  4 , Annamari Tuulio-Henriksson  2 , Ilkka Järvinen  2 , Eliisa Lehto  2 , Katarina Michelsson  5 , Laura Hokkanen  2
Affiliations

Mortality in individuals with childhood ADHD or subthreshold symptoms - a prospective perinatal risk cohort study over 40 years

Nella Schiavone et al. BMC Psychiatry. .

Abstract

Background: Attention-deficit/hyperactivity disorder (ADHD) is associated with negative life outcomes and recent studies have linked it to increased mortality. These studies have examined nationwide registers or clinic-referred samples and mostly included participants up until the age of 30. No studies have investigated mortality associated with subthreshold levels of ADHD symptoms. Our aim was to analyze mortality in a perinatal risk cohort of 46-year-old adults with childhood ADHD (cADHD) and milder childhood attention problems (including hyperactivity and inattention; cAP) compared with a group with similar birth risks but no or low levels of childhood ADHD symptoms (Non-cAP). Causes of death obtained from a national register were examined.

Methods: Mortality was analyzed with Cox proportional hazard models for all-cause mortality, cause-specific mortality (natural and unnatural causes), and age-specific mortality (under and over age 30). All models were adjusted with gender. The total n in the study was 839 (cADHD n = 115; cAP n = 216; Non-cAP n = 508).

Results: By the age of 46, 11 (9.6%) deaths occurred in the cADHD group, 7 (3.2%) in the cAP group, and 20 (3.9%) in the Non-cAP group. The cADHD group had the highest mortality risk (adjusted hazard ratio = 2.15; 95% CI 1.02, 4.54). Mortality was not elevated in the cAP group (adjusted hazard ratio = 0.72; 95% CI .30, 1.72). Mortality in the cADHD group was mainly attributed to unnatural causes of death (adjusted hazard ratio = 2.82; 95% CI 1.12, 7.12). The mortality risk in the cADHD group was sixfold before age 30 (adjusted hazard ratio = 6.20; 95% CI 1.78, 21.57).

Conclusions: Childhood ADHD was associated with a twofold risk of premature death by the age of 46 in this prospective longitudinal cohort study. Our results corroborate previous findings and the morbidity of ADHD. Subthreshold levels of childhood ADHD symptoms were not linked to increased mortality. Our results suggest that mortality risk is higher in young than middle adulthood. Future studies should examine mortality associated with ADHD in different ages in adulthood to identify those in greatest risk of premature death.

Keywords: ADHD; Adult; Cohort; Mortality; Perinatal risk; Subthreshold ADHD.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of the participants from birth to the 46-year follow-up. Note. cADHD = childhood ADHD, cAP = childhood attention problems, Non-cAP = no childhood attention problems
Fig. 2
Fig. 2
Cumulative survival in childhood groups. Note. cADHD = childhood ADHD, cAP = childhood attention problems, Non-cAP = no childhood attention problems
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fayyad J, Sampson NA, Hwang I, Adamowski T, Aguilar-Gaxiola S, Al-Hamzawi A, et al. The descriptive epidemiology of DSM-IV Adult ADHD in the world health organization world mental health surveys. ADHD Atten Deficit Hyperact Disord. 2017;9(1):47–65. doi: 10.1007/s12402-016-0208-3. - DOI - PMC - PubMed
    1. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry Allied Discip. 2015;56(3):345–365. doi: 10.1111/jcpp.12381. - DOI - PubMed
    1. Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012;10:99. doi: 10.1186/1741-7015-10-99. - DOI - PMC - PubMed
    1. Klein RG, Mannuzza S, Ramos Olazagasti M a, Roizen Belsky E, Hutchison JA, Lashua-Shriftman E, et al. Clinical and functional outcome of childhood ADHD 33 years later. Arch Gen Psychiatry. 2012;69:1295–303. doi: 10.1001/archgenpsychiatry.2012.271. - DOI - PMC - PubMed
    1. Septier M, Stordeur C, Zhang J, Delorme R, Cortese S. Association between suicidal spectrum behaviors and Attention-Deficit/Hyperactivity Disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2019;103:109–118. doi: 10.1016/j.neubiorev.2019.05.022. - DOI - PubMed

Publication types